Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
15.5M
-
Shares change
-
+228K
-
Total reported value, excl. options
-
$81.7M
-
Value change
-
+$645K
-
Put/Call ratio
-
2
-
Number of buys
-
31
-
Number of sells
-
-27
-
Price
-
$5.27
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q3 2019
79 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2019.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.5M shares
of 60M outstanding shares and own 25.82% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.09M shares), 683 Capital Management, LLC (2.35M shares), BlackRock Inc. (1.59M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.42M shares), VANGUARD GROUP INC (1.13M shares), SPHERA FUNDS MANAGEMENT LTD. (1.07M shares), Prosight Management, LP (790K shares), MILLENNIUM MANAGEMENT LLC (534K shares), Knoll Capital Management, LP (532K shares), and STATE STREET CORP (399K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.